Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
EHC Stock Forecast 2025-2026
$119.77
Current Price
$12.07B
Market Cap
Buy 12
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to EHC Price Targets
+16.9%
To High Target of $140.00
+8.5%
To Median Target of $130.00
+1.9%
To Low Target of $122.00
EHC Price Momentum
+2.9%
1 Week Change
+16.3%
1 Month Change
+40.2%
1 Year Change
+29.7%
Year-to-Date Change
-0.2%
From 52W High of $119.95
+44.8%
From 52W Low of $82.74
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Encompass Health (EHC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on EHC and similar high-potential opportunities.
Latest EHC Stock Price Targets & Analyst Predictions
Based on our analysis of 19 Wall Street analysts, EHC has a bullish consensus with a median price target of $130.00 (ranging from $122.00 to $140.00). Currently trading at $119.77, the median forecast implies a 8.5% upside. This outlook is supported by 12 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Matthew Gillmor at Keybanc, suggesting a 1.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EHC Analyst Ratings
12
Buy
0
Hold
0
Sell
EHC Price Target Range
Low
$122.00
Average
$130.00
High
$140.00
Current: $119.77
Latest EHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 28, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $125.00 |
| Apr 28, 2025 | Truist Securities | David Macdonald | Buy | Reiterates | $135.00 |
| Apr 28, 2025 | UBS | Andrew Mok | Buy | Maintains | $130.00 |
| Apr 25, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $129.00 |
| Apr 25, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $122.00 |
| Feb 11, 2025 | RBC Capital | Ben Hendrix | Outperform | Reiterates | $110.00 |
| Feb 10, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $120.00 |
| Feb 7, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $118.00 |
| Oct 30, 2024 | Truist Securities | David Macdonald | Buy | Reiterates | $116.00 |
| Oct 30, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $110.00 |
| Oct 29, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $116.00 |
| Oct 29, 2024 | Keybanc | Matthew Gillmor | Overweight | Maintains | $117.00 |
| Oct 14, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $108.00 |
| Oct 11, 2024 | Keybanc | Matthew Gillmor | Overweight | Initiates | $115.00 |
| Sep 26, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $105.00 |
| Sep 25, 2024 | UBS | Andrew Mok | Buy | Maintains | $110.00 |
| Aug 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $104.00 |
| Aug 8, 2024 | UBS | Andrew Mok | Buy | Maintains | $100.00 |
| Aug 6, 2024 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $105.00 |
| Aug 6, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $109.00 |
Encompass Health Corporation (EHC) Competitors
The following stocks are similar to Encompass Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
EHC
Encompass Health
mkt cap
11.73B
Encompass Health Corporation (EHC) Financial Data
Encompass Health Corporation has a market capitalization of $12.07B with a P/E ratio of 24.6x. The company generates $5.51B in trailing twelve-month revenue with a 9.0% profit margin.
Revenue growth is +10.6% quarter-over-quarter, while maintaining an operating margin of +18.3% and return on equity of +24.6%.
Valuation Metrics
Market Cap
$12.07B
Enterprise Value
$15.46B
P/E Ratio
24.6x
PEG Ratio
25.1x
Price/Sales
2.2x
Growth & Margins
Revenue Growth (YoY)
+10.6%
Gross Margin
+43.3%
Operating Margin
+18.3%
Net Margin
+9.0%
EPS Growth
+34.7%
Financial Health
Cash/Price Ratio
+0.8%
Current Ratio
1.1x
Debt/Equity
92.0x
ROE
+24.6%
ROA
+9.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Encompass Health Corporation (EHC) Business Model
About Encompass Health Corporation
What They Do
Provides post-acute healthcare services.
Business Model
The company operates a network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies, generating revenue through the provision of specialized post-acute care services. By focusing on high-quality, cost-effective care, Encompass Health enhances patient recovery outcomes and addresses the increasing demand for comprehensive rehabilitation solutions.
Additional Information
Encompass Health plays a vital role in the healthcare sector, facilitating smooth transitions for patients from hospitals to recovery and long-term care. Its services contribute to the modernization and efficiency of healthcare delivery, making it an integral player in the industry.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
28,572
CEO
Mr. Mark J. Tarr
Country
United States
IPO Year
2017
Website
www.encompasshealth.comEncompass Health Corporation (EHC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
May 15, 2025
By Zacks Equity Research
52 Week High
The Joint Misses Q1 Earnings Estimates on Rising Expenses
JYNT expects to open 30-40 franchised clinics in 2025, down from 57 last year.
May 14, 2025
By Zacks Equity Research
Analyst Blog
Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions
ACHC continues to witness growth in patient days. It authorizes a share repurchase program of almost $300 million.
May 13, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
EHC operates 167 hospitals across 38 states and Puerto Rico, indicating a significant presence in the healthcare sector.
Why It Matters
EHC's extensive network of 167 hospitals enhances its market presence, potentially driving revenue growth and improving competitive positioning in the healthcare sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Encompass Health (EHC) has reached a 52-week high; analysts are examining the company's fundamentals to assess potential for future gains.
Why It Matters
Encompass Health's 52-week high signals strong performance, but assessing fundamentals is crucial for gauging potential future growth and investment viability.
Source: Zacks Investment Research
Market Sentiment:
Positive
Best Growth Stocks to Buy for May 15th
1 day ago
Quick Summary
EHC, GLDD, and BSAC were added to the Zacks Rank #1 (Strong Buy) growth stocks list on May 15, 2025.
Why It Matters
EHC, GLDD, and BSAC's inclusion in the Zacks Rank #1 (Strong Buy) list signals strong growth potential, attracting investor interest and possibly influencing stock price performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Healthcare stocks have performed relatively well amid concerns over Medicare and Medicaid cuts and tariffs, despite a turbulent start to the year compared to energy and IT sectors.
Why It Matters
Healthcare stocks are outperforming others despite challenges, indicating resilience and potential for growth, which can influence investment strategies and market confidence.
Source: MarketBeat
Market Sentiment:
Neutral
Quick Summary
Zacks Style Scores help investors identify top-rated stocks tailored to their investing style, providing a strategic tool for stock selection.
Why It Matters
Zacks Style Scores help identify high-potential stocks tailored to specific investment strategies, enhancing decision-making and increasing the likelihood of profitable investments.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Encompass Health (EHC) has received a Zacks Rank #1 (Strong Buy) upgrade, indicating increased optimism about its earnings prospects, which may boost the stock's value soon.
Why It Matters
The Zacks Rank #1 upgrade signals strong earnings potential for Encompass Health, likely attracting more investors and pushing the stock price upward.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About EHC Stock
What is Encompass Health Corporation's (EHC) stock forecast for 2025?
Based on our analysis of 19 Wall Street analysts, Encompass Health Corporation (EHC) has a median price target of $130.00. The highest price target is $140.00 and the lowest is $122.00.
Is EHC stock a good investment in 2025?
According to current analyst ratings, EHC has 12 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $119.77. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for EHC stock?
Wall Street analysts predict EHC stock could reach $130.00 in the next 12 months. This represents a 8.5% increase from the current price of $119.77. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Encompass Health Corporation's business model?
The company operates a network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies, generating revenue through the provision of specialized post-acute care services. By focusing on high-quality, cost-effective care, Encompass Health enhances patient recovery outcomes and addresses the increasing demand for comprehensive rehabilitation solutions.
What is the highest forecasted price for EHC Encompass Health Corporation?
The highest price target for EHC is $140.00 from at , which represents a 16.9% increase from the current price of $119.77.
What is the lowest forecasted price for EHC Encompass Health Corporation?
The lowest price target for EHC is $122.00 from Matthew Gillmor at Keybanc, which represents a 1.9% increase from the current price of $119.77.
What is the overall EHC consensus from analysts for Encompass Health Corporation?
The overall analyst consensus for EHC is bullish. Out of 19 Wall Street analysts, 12 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $130.00.
How accurate are EHC stock price projections?
Stock price projections, including those for Encompass Health Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 1:49 PM UTC